Transcatheter aortic valve thrombosis - PubMed
6 hours ago
- #valve thrombosis
- #antithrombotic therapy
- #TAVI
- Transcatheter aortic valve implantation (TAVI) is increasingly used in younger and lower-risk patients, raising concerns about valve thrombosis.
- Valve thrombosis in TAVI prostheses can lead to bioprosthetic valve dysfunction and thromboembolic events.
- Detection of valve thrombosis is challenged by differences in sensitivity and heterogeneity among imaging modalities.
- Long-term implications of valve thrombosis, including stroke risk and prosthesis longevity, remain uncertain.
- Current treatment options include anticoagulation therapy, thrombolysis, and reintervention in some cases.
- Ongoing research focuses on improving detection and treatment through standardized imaging protocols and antithrombotic regimens.
- Prevention requires better understanding of patient- and procedure-related risk factors to individualize therapy and improve prosthesis design.
- The review outlines mechanisms, prevalence, clinical relevance, and management of TAVI thrombosis, highlighting ongoing clinical trials.